With less than a year until the 2026 midterm elections, it's already expected to be one of the most expensive campaigns in history. But how that money is spent could be changing. Major arguments took ...

Ahead of midterms, justices consider GOP bid to roll back anti-corruption law. As candidates and political parties gear up for the 2026 midterm election campaign, the Supreme Court on Tuesday will ...

WASHINGTON, Dec 1 (Reuters) - U.S. manufacturing contracted for the ninth straight month in November, with factories facing slumping orders and higher prices for inputs as the drag from import tariffs ...

AI giant OpenAI has revealed its API metadata was exposed in a security breach. A phishing incident at third-party data analytics provider Mixpanel compromised user details, including names, email ...

Reviving and restoring America’s migrating manufacturing base was one of the marquee pledges of President Donald Trump’s successful 2024 campaign. But this renaissance has yet to materialize and ...

Zohran Mamdani has won New York City's mayoral election. The self-described democratic socialist has promised New Yorkers a cornucopia of policies, programs, and services. There's ample reason to ...

SAN JOSE, Calif.—Roku has launched Roku Ads API, a fully open, self-serve developer platform for connected TV (CTV) advertising. The Roku Ads API gives developers direct access to Roku’s first-party ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

Battlefield campaigns have struggled with their identity throughout the series’ history. Where Call of Duty, Battlefield's top competitor in first-person shooters, has two storylines running through ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...